Skip to content

Promore – Reports and prospectus

Interim Reports (Promore) November 24, 2020 Interim report January – September 2020 Report (pdf)
Interim Reports (Promore) August 25, 2020 Promore Pharma AB (publ) Interim report January – June 2020 Report (pdf)
Interim Reports (Promore) May 26, 2020 Promore Pharma AB (publ) Interim report January – March 2020 Report (pdf)
Interim Reports (Promore) February 18, 2020 Promore Pharma AB (publ) Year-end report 2019 Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.